SIMILAR PATTERN OF AMINO ACIDS MAPPED TO '2gl8'

List of Similar Pattern of Amino Acids

Hit pattern: 3D amino acid arrangements similar to known drug binding site
Query pattern: Residues from known binding site for annotated drug that match the hit pattern

(Click on the DrReposER ID to view details on interfaces and similar patterns of amino acids)
(Click on the view link on the last column to view superposed patterns of amino acids)

Filter list by:

	DrReposER ID / Desc.	Hit PDBID	Hit Macromolecule	Res. Matches	Interface	HETATM	RMSD	Dali Z-score	Seq. Identity (%)
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	1FBY_A_9CRA500_1 (RETINOIC ACID RECEPTOR RXR-ALPHA)	2gl8	RETINOIC ACID RECEPTOR RXR-GAMMA (Homo sapiens)	6 / 12	PHE A 92 ARG A 95 LEU A 105 ALA A 106 VAL A 121 CYH A 211	None	0.86A	1fbyA-2gl8A: 27.5	1fbyA-2gl8A: 85.25
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	1FBY_B_9CRB1500_1 (RETINOIC ACID RECEPTOR RXR-ALPHA)	2gl8	RETINOIC ACID RECEPTOR RXR-GAMMA (Homo sapiens)	6 / 12	PHE A 92 ARG A 95 LEU A 105 ALA A 106 VAL A 121 CYH A 211	None	0.88A	1fbyB-2gl8A: 27.0	1fbyB-2gl8A: 85.25
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	1FM6_A_9CRA501_1 (RETINOIC ACID RECEPTOR RXR-ALPHA)	2gl8	RETINOIC ACID RECEPTOR RXR-GAMMA (Homo sapiens)	7 / 12	TRP A 84 PHE A 92 ARG A 95 LEU A 105 ALA A 106 VAL A 121 CYH A 211	None	0.81A	1fm6A-2gl8A: 26.8	1fm6A-2gl8A: 85.60
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	1FM6_U_9CRU502_1 (RETINOIC ACID RECEPTOR RXR-ALPHA)	2gl8	RETINOIC ACID RECEPTOR RXR-GAMMA (Homo sapiens)	7 / 12	PHE A 92 ARG A 95 LEU A 105 ALA A 106 VAL A 121 ILE A 124 CYH A 211	None	0.75A	1fm6U-2gl8A: 26.7	1fm6U-2gl8A: 85.60
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	1FM9_A_9CRA201_1 (RETINOIC ACID RECEPTOR RXR-ALPHA)	2gl8	RETINOIC ACID RECEPTOR RXR-GAMMA (Homo sapiens)	8 / 12	TRP A 84 LEU A 88 PHE A 92 ARG A 95 LEU A 105 ALA A 106 VAL A 121 CYH A 211	None	0.74A	1fm9A-2gl8A: 27.2	1fm9A-2gl8A: 85.60
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	1G5Y_C_9CRC502_1 (RETINOIC ACID RECEPTOR RXR-ALPHA)	2gl8	RETINOIC ACID RECEPTOR RXR-GAMMA (Homo sapiens)	6 / 10	LEU A 88 SER A 91 PHE A 92 ARG A 95 LEU A 105 ALA A 106	None	0.88A	1g5yC-2gl8A: 28.5	1g5yC-2gl8A: 85.60
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	1K74_A_9CRA463_1 (RETINOIC ACID RECEPTOR RXR-ALPHA)	2gl8	RETINOIC ACID RECEPTOR RXR-GAMMA (Homo sapiens)	8 / 12	TRP A 84 LEU A 88 PHE A 92 ARG A 95 LEU A 105 ALA A 106 VAL A 121 CYH A 211	None	0.80A	1k74A-2gl8A: 27.0	1k74A-2gl8A: 85.60
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	1XDK_A_9CRA500_1 (RETINOIC ACID RECEPTOR RXR-ALPHA)	2gl8	RETINOIC ACID RECEPTOR RXR-GAMMA (Homo sapiens)	7 / 12	TRP A 84 PHE A 92 ARG A 95 LEU A 105 ALA A 106 VAL A 121 CYH A 211	None	0.78A	1xdkA-2gl8A: 27.0	1xdkA-2gl8A: 85.19
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	1XDK_E_9CRE1500_1 (RETINOIC ACID RECEPTOR RXR-ALPHA)	2gl8	RETINOIC ACID RECEPTOR RXR-GAMMA (Homo sapiens)	7 / 12	TRP A 84 PHE A 92 ARG A 95 LEU A 105 ALA A 106 VAL A 121 CYH A 211	None	0.78A	1xdkE-2gl8A: 27.0	1xdkE-2gl8A: 85.19
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	1XIU_A_9CRA201_1 (RXR-LIKE PROTEIN)	2gl8	RETINOIC ACID RECEPTOR RXR-GAMMA (Homo sapiens)	6 / 12	PHE A 92 ARG A 95 LEU A 105 ALA A 106 VAL A 121 CYH A 211	None	0.81A	1xiuA-2gl8A: 28.0	1xiuA-2gl8A: 78.01
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	1XIU_B_9CRB202_1 (RXR-LIKE PROTEIN)	2gl8	RETINOIC ACID RECEPTOR RXR-GAMMA (Homo sapiens)	6 / 12	LEU A 88 PHE A 92 ARG A 95 ALA A 106 VAL A 121 CYH A 211	None	0.57A	1xiuB-2gl8A: 27.7	1xiuB-2gl8A: 78.01
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	1XLS_A_9CRA801_1 (RETINOIC ACID RECEPTOR RXR-ALPHA)	2gl8	RETINOIC ACID RECEPTOR RXR-GAMMA (Homo sapiens)	8 / 12	TRP A 84 LEU A 88 PHE A 92 ARG A 95 LEU A 105 ALA A 106 VAL A 121 CYH A 211	None	0.79A	1xlsA-2gl8A: 26.8	1xlsA-2gl8A: 86.50
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	1XLS_B_9CRB802_1 (RETINOIC ACID RECEPTOR RXR-ALPHA)	2gl8	RETINOIC ACID RECEPTOR RXR-GAMMA (Homo sapiens)	8 / 12	TRP A 84 LEU A 88 PHE A 92 ARG A 95 LEU A 105 ALA A 106 VAL A 121 CYH A 211	None	0.78A	1xlsB-2gl8A: 26.8	1xlsB-2gl8A: 86.50
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	1XLS_C_9CRC803_1 (RETINOIC ACID RECEPTOR RXR-ALPHA)	2gl8	RETINOIC ACID RECEPTOR RXR-GAMMA (Homo sapiens)	8 / 12	TRP A 84 LEU A 88 PHE A 92 ARG A 95 LEU A 105 ALA A 106 VAL A 121 CYH A 211	None	0.78A	1xlsC-2gl8A: 26.7	1xlsC-2gl8A: 86.50
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	1XLS_D_9CRD804_1 (RETINOIC ACID RECEPTOR RXR-ALPHA)	2gl8	RETINOIC ACID RECEPTOR RXR-GAMMA (Homo sapiens)	8 / 12	TRP A 84 LEU A 88 PHE A 92 ARG A 95 LEU A 105 ALA A 106 VAL A 121 CYH A 211	None	0.79A	1xlsD-2gl8A: 26.7	1xlsD-2gl8A: 86.50
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	2ACL_A_REAA502_1 (RETINOIC ACID RECEPTOR RXR-ALPHA)	2gl8	RETINOIC ACID RECEPTOR RXR-GAMMA (Homo sapiens)	6 / 12	ASN A 85 LEU A 88 ARG A 95 ALA A 106 ILE A 124 CYH A 211	None	1.00A	2aclA-2gl8A: 27.9 2aclE-2gl8A: 27.7	2aclA-2gl8A: 85.60 2aclE-2gl8A: 85.60
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	2ACL_A_REAA502_1 (RETINOIC ACID RECEPTOR RXR-ALPHA)	2gl8	RETINOIC ACID RECEPTOR RXR-GAMMA (Homo sapiens)	7 / 12	LEU A 88 PHE A 92 ARG A 95 LEU A 105 ALA A 106 ILE A 124 CYH A 211	None	0.90A	2aclA-2gl8A: 27.9 2aclE-2gl8A: 27.7	2aclA-2gl8A: 85.60 2aclE-2gl8A: 85.60
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	2ACL_C_REAC503_1 (RETINOIC ACID RECEPTOR RXR-ALPHA)	2gl8	RETINOIC ACID RECEPTOR RXR-GAMMA (Homo sapiens)	5 / 10	PHE A 92 ARG A 95 ALA A 106 ILE A 124 CYH A 211	None	0.83A	2aclC-2gl8A: 27.9	2aclC-2gl8A: 85.60
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	2ACL_E_REAE504_1 (RETINOIC ACID RECEPTOR RXR-ALPHA)	2gl8	RETINOIC ACID RECEPTOR RXR-GAMMA (Homo sapiens)	6 / 11	LEU A 88 PHE A 92 ARG A 95 ALA A 106 ILE A 124 CYH A 211	None	0.94A	2aclE-2gl8A: 27.7	2aclE-2gl8A: 85.60
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	2ACL_G_REAG501_1 (RETINOIC ACID RECEPTOR RXR-ALPHA)	2gl8	RETINOIC ACID RECEPTOR RXR-GAMMA (Homo sapiens)	6 / 12	ASN A 85 ILE A 89 PHE A 92 ARG A 95 ALA A 106 CYH A 211	None	1.02A	2aclG-2gl8A: 27.1	2aclG-2gl8A: 85.60
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	2ACL_G_REAG501_1 (RETINOIC ACID RECEPTOR RXR-ALPHA)	2gl8	RETINOIC ACID RECEPTOR RXR-GAMMA (Homo sapiens)	6 / 12	ASN A 85 LEU A 88 ILE A 89 PHE A 92 ALA A 106 CYH A 211	None	0.71A	2aclG-2gl8A: 27.1	2aclG-2gl8A: 85.60
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	2ACL_G_REAG501_1 (RETINOIC ACID RECEPTOR RXR-ALPHA)	2gl8	RETINOIC ACID RECEPTOR RXR-GAMMA (Homo sapiens)	6 / 12	ILE A 89 PHE A 92 ARG A 95 LEU A 105 ALA A 106 CYH A 211	None	1.02A	2aclG-2gl8A: 27.1	2aclG-2gl8A: 85.60
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	2ACL_G_REAG501_1 (RETINOIC ACID RECEPTOR RXR-ALPHA)	2gl8	RETINOIC ACID RECEPTOR RXR-GAMMA (Homo sapiens)	6 / 12	LEU A 88 ILE A 89 PHE A 92 LEU A 105 ALA A 106 CYH A 211	None	0.86A	2aclG-2gl8A: 27.1	2aclG-2gl8A: 85.60
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2AOF_C_FRDC305_2 (POL POLYPROTEIN PEPTIDE INHIBITOR)	2gl8	RETINOIC ACID RECEPTOR RXR-GAMMA (Homo sapiens)	4 / 5	LEU A 79 ASP A 75 ALA A 159 ILE A 78	None	0.93A	2aofB-2gl8A: undetectable	2aofB-2gl8A: 19.82
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2CEO_B_T44B1395_1 (THYROXINE-BINDING GLOBULIN)	2gl8	RETINOIC ACID RECEPTOR RXR-GAMMA (Homo sapiens)	5 / 10	ALA A 159 LEU A 171 LEU A 71 LEU A 162 ASN A 164	None	1.36A	2ceoB-2gl8A: undetectable	2ceoB-2gl8A: 20.82
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2QQD_A_AG2A671_1 (PYRUVOYL-DEPENDENT ARGININE DECARBOXYLASE (EC 4.1.1.19) (PVLARGDC))	2gl8	RETINOIC ACID RECEPTOR RXR-GAMMA (Homo sapiens)	4 / 7	LEU A 146 LEU A 204 ILE A 152 GLU A 21	None	1.06A	2qqdA-2gl8A: undetectable 2qqdE-2gl8A: undetectable	2qqdA-2gl8A: 12.55 2qqdE-2gl8A: 17.30
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3DZU_A_9CRA7223_1 (RETINOIC ACID RECEPTOR RXR-ALPHA)	2gl8	RETINOIC ACID RECEPTOR RXR-GAMMA (Homo sapiens)	6 / 12	ASN A 85 ILE A 89 PHE A 92 ARG A 95 VAL A 121 CYH A 211	None	0.54A	3dzuA-2gl8A: 26.7	3dzuA-2gl8A: 48.28
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3DZU_A_9CRA7223_1 (RETINOIC ACID RECEPTOR RXR-ALPHA)	2gl8	RETINOIC ACID RECEPTOR RXR-GAMMA (Homo sapiens)	6 / 12	ILE A 89 PHE A 92 ARG A 95 LEU A 105 VAL A 121 CYH A 211	None	0.60A	3dzuA-2gl8A: 26.7	3dzuA-2gl8A: 48.28
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3DZY_A_9CRA463_1 (RETINOIC ACID RECEPTOR RXR-ALPHA)	2gl8	RETINOIC ACID RECEPTOR RXR-GAMMA (Homo sapiens)	7 / 12	ASN A 85 SER A 91 PHE A 92 ARG A 95 ALA A 106 VAL A 121 CYH A 211	None	0.95A	3dzyA-2gl8A: 25.8	3dzyA-2gl8A: 48.28
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3DZY_A_9CRA463_1 (RETINOIC ACID RECEPTOR RXR-ALPHA)	2gl8	RETINOIC ACID RECEPTOR RXR-GAMMA (Homo sapiens)	7 / 12	SER A 91 PHE A 92 ARG A 95 LEU A 105 ALA A 106 VAL A 121 CYH A 211	None	0.93A	3dzyA-2gl8A: 25.8	3dzyA-2gl8A: 48.28
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3E00_A_9CRA7223_1 (RETINOIC ACID RECEPTOR RXR-ALPHA)	2gl8	RETINOIC ACID RECEPTOR RXR-GAMMA (Homo sapiens)	7 / 12	TRP A 84 PHE A 92 ARG A 95 ALA A 106 VAL A 121 ILE A 124 CYH A 211	None	0.71A	3e00A-2gl8A: 27.5	3e00A-2gl8A: 48.28
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3FAL_A_REAA501_1 (RETINOIC ACID RECEPTOR RXR-ALPHA)	2gl8	RETINOIC ACID RECEPTOR RXR-GAMMA (Homo sapiens)	6 / 10	PHE A 92 ARG A 95 ALA A 106 VAL A 121 ILE A 124 CYH A 211	None	0.76A	3falA-2gl8A: 27.7	3falA-2gl8A: 85.66
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3FAL_C_REAC501_1 (RETINOIC ACID RECEPTOR RXR-ALPHA)	2gl8	RETINOIC ACID RECEPTOR RXR-GAMMA (Homo sapiens)	6 / 10	PHE A 92 ARG A 95 LEU A 105 ALA A 106 ILE A 124 CYH A 211	None	0.84A	3falC-2gl8A: 28.1	3falC-2gl8A: 85.66
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3FC6_A_REAA501_1 (RETINOIC ACID RECEPTOR RXR-ALPHA)	2gl8	RETINOIC ACID RECEPTOR RXR-GAMMA (Homo sapiens)	7 / 11	TRP A 84 PHE A 92 ARG A 95 LEU A 105 ALA A 106 ILE A 124 CYH A 211	None	0.82A	3fc6A-2gl8A: 28.1	3fc6A-2gl8A: 85.66
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3FC6_C_REAC501_1 (RETINOIC ACID RECEPTOR RXR-ALPHA)	2gl8	RETINOIC ACID RECEPTOR RXR-GAMMA (Homo sapiens)	6 / 12	LEU A 88 PHE A 92 ARG A 95 ALA A 106 VAL A 121 CYH A 211	None	0.73A	3fc6C-2gl8A: 28.9	3fc6C-2gl8A: 85.66
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3FC6_C_REAC501_1 (RETINOIC ACID RECEPTOR RXR-ALPHA)	2gl8	RETINOIC ACID RECEPTOR RXR-GAMMA (Homo sapiens)	6 / 12	PHE A 92 ARG A 95 LEU A 105 ALA A 106 VAL A 121 CYH A 211	None	0.81A	3fc6C-2gl8A: 28.9	3fc6C-2gl8A: 85.66
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3H0A_A_9RAA500_1 (RETINOIC ACID RECEPTOR RXR-ALPHA)	2gl8	RETINOIC ACID RECEPTOR RXR-GAMMA (Homo sapiens)	6 / 12	LEU A 88 ARG A 95 LEU A 105 VAL A 121 ILE A 124 CYH A 211	None	1.01A	3h0aA-2gl8A: 25.7	3h0aA-2gl8A: 88.60
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3H0A_A_9RAA500_1 (RETINOIC ACID RECEPTOR RXR-ALPHA)	2gl8	RETINOIC ACID RECEPTOR RXR-GAMMA (Homo sapiens)	6 / 12	TRP A 84 LEU A 88 ARG A 95 LEU A 105 VAL A 121 ILE A 124	None	0.86A	3h0aA-2gl8A: 25.7	3h0aA-2gl8A: 88.60
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3OAP_A_9CRA500_1 (RETINOIC ACID RECEPTOR RXR-ALPHA)	2gl8	RETINOIC ACID RECEPTOR RXR-GAMMA (Homo sapiens)	7 / 12	PHE A 92 ARG A 95 LEU A 105 ALA A 106 VAL A 121 ILE A 124 CYH A 211	None	0.71A	3oapA-2gl8A: 28.5	3oapA-2gl8A: 88.31
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3UVV_B_9CRB501_1 (RETINOIC ACID RECEPTOR RXR-ALPHA)	2gl8	RETINOIC ACID RECEPTOR RXR-GAMMA (Homo sapiens)	7 / 12	LEU A 88 PHE A 92 ARG A 95 ALA A 106 VAL A 121 ILE A 124 CYH A 211	None	0.64A	3uvvB-2gl8A: 28.0	3uvvB-2gl8A: 85.66
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4K6I_A_9RAA500_1 (RETINOIC ACID RECEPTOR RXR-ALPHA)	2gl8	RETINOIC ACID RECEPTOR RXR-GAMMA (Homo sapiens)	6 / 12	LEU A 88 ILE A 89 PHE A 92 ARG A 95 ALA A 106 VAL A 128	None	0.61A	4k6iA-2gl8A: 28.1	4k6iA-2gl8A: 88.31
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4KLA_A_CHDA502_0 (FERROCHELATASE, MITOCHONDRIAL)	2gl8	RETINOIC ACID RECEPTOR RXR-GAMMA (Homo sapiens)	5 / 8	LEU A 154 LEU A 87 LEU A 88 ILE A 65 VAL A 24	None	1.37A	4klaA-2gl8A: undetectable	4klaA-2gl8A: 22.69
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4NQA_A_9CRA501_1 (RETINOIC ACID RECEPTOR RXR-ALPHA)	2gl8	RETINOIC ACID RECEPTOR RXR-GAMMA (Homo sapiens)	5 / 11	ILE A 89 ARG A 200 LEU A 204 ALA A 203 LEU A 215	None	1.05A	4nqaA-2gl8A: 26.4	4nqaA-2gl8A: 60.97
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4NQA_A_9CRA501_1 (RETINOIC ACID RECEPTOR RXR-ALPHA)	2gl8	RETINOIC ACID RECEPTOR RXR-GAMMA (Homo sapiens)	5 / 11	PHE A 92 LEU A 105 ALA A 106 VAL A 121 CYH A 211	None	0.94A	4nqaA-2gl8A: 26.4	4nqaA-2gl8A: 60.97
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	5JI0_A_9CRA501_1 (RETINOIC ACID RECEPTOR RXR-ALPHA)	2gl8	RETINOIC ACID RECEPTOR RXR-GAMMA (Homo sapiens)	8 / 11	TRP A 84 LEU A 88 PHE A 92 ARG A 95 LEU A 105 ALA A 106 VAL A 121 CYH A 211	None	0.71A	5ji0A-2gl8A: 27.6	5ji0A-2gl8A: 84.84
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	5UAN_A_9CRA503_1 (RETINOIC ACID RECEPTOR RXR-ALPHA)	2gl8	RETINOIC ACID RECEPTOR RXR-GAMMA (Homo sapiens)	6 / 12	TRP A 84 PHE A 92 ARG A 95 ALA A 106 VAL A 121 CYH A 211	None	0.99A	5uanA-2gl8A: 26.5	5uanA-2gl8A: 60.97
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	5UAN_A_9CRA503_1 (RETINOIC ACID RECEPTOR RXR-ALPHA)	2gl8	RETINOIC ACID RECEPTOR RXR-GAMMA (Homo sapiens)	6 / 12	TRP A 84 PHE A 92 LEU A 105 ALA A 106 VAL A 121 CYH A 211	None	0.95A	5uanA-2gl8A: 26.5	5uanA-2gl8A: 60.97
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	5Z12_B_9CRB501_1 (RETINOIC ACID RECEPTOR RXR-ALPHA)	2gl8	RETINOIC ACID RECEPTOR RXR-GAMMA (Homo sapiens)	8 / 12	TRP A 84 LEU A 88 PHE A 92 ARG A 95 LEU A 105 ALA A 106 VAL A 121 CYH A 211	None	0.72A	5z12B-2gl8A: 27.7	5z12B-2gl8A: 83.75
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	5Z12_C_9CRC501_1 (RETINOIC ACID RECEPTOR RXR-ALPHA)	2gl8	RETINOIC ACID RECEPTOR RXR-GAMMA (Homo sapiens)	7 / 12	TRP A 84 PHE A 92 ARG A 95 LEU A 105 ALA A 106 VAL A 121 CYH A 211	None	0.70A	5z12C-2gl8A: 26.9	5z12C-2gl8A: 83.75
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	6A5Y_D_9CRD501_0 (RETINOIC ACID RECEPTOR RXR-ALPHA)	2gl8	RETINOIC ACID RECEPTOR RXR-GAMMA (Homo sapiens)	7 / 12	TRP A 84 PHE A 92 ARG A 95 LEU A 105 ALA A 106 ILE A 124 CYH A 211	None	0.77A	6a5yD-2gl8A: 28.3	6a5yD-2gl8A: 77.65
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	6A5Z_D_9CRD501_0 (RETINOIC ACID RECEPTOR RXR-ALPHA)	2gl8	RETINOIC ACID RECEPTOR RXR-GAMMA (Homo sapiens)	7 / 12	ILE A 89 PHE A 92 ARG A 95 LEU A 105 ALA A 106 ILE A 124 CYH A 211	None	0.69A	6a5zD-2gl8A: 28.2	6a5zD-2gl8A: 77.65
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	6A5Z_L_9CRL501_0 (RETINOIC ACID RECEPTOR RXR-ALPHA)	2gl8	RETINOIC ACID RECEPTOR RXR-GAMMA (Homo sapiens)	6 / 12	PHE A 92 ARG A 95 LEU A 105 ALA A 106 ILE A 124 CYH A 211	None	0.73A	6a5zL-2gl8A: 28.2	6a5zL-2gl8A: 77.65
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	6A60_D_9CRD501_0 (RETINOIC ACID RECEPTOR RXR-ALPHA)	2gl8	RETINOIC ACID RECEPTOR RXR-GAMMA (Homo sapiens)	6 / 12	LEU A 88 PHE A 92 ARG A 95 ALA A 106 ILE A 124 CYH A 211	None	0.67A	6a60D-2gl8A: 28.0	6a60D-2gl8A: 77.65

[["DrReposER ID","Desc.","Hit PDB","Hit molecule","Hit organism","Res. no.","Interface","HETATM","RMSD","Z-score","Seq ID"],["1FBY_A_9CRA500_1","RETINOIC ACID RECEPTOR RXR-ALPHA","2gl8","RETINOIC ACID RECEPTOR RXR-GAMMA","Homo sapiens",6,"PHE A  92;ARG A  95;LEU A 105;ALA A 106;VAL A 121;CYH A 211","None","0.86A","1fbyA-2gl8A:27.5","1fbyA-2gl8A:85.25"],["1FBY_B_9CRB1500_1","RETINOIC ACID RECEPTOR RXR-ALPHA","2gl8","RETINOIC ACID RECEPTOR RXR-GAMMA","Homo sapiens",6,"PHE A  92;ARG A  95;LEU A 105;ALA A 106;VAL A 121;CYH A 211","None","0.88A","1fbyB-2gl8A:27.0","1fbyB-2gl8A:85.25"],["1FM6_A_9CRA501_1","RETINOIC ACID RECEPTOR RXR-ALPHA","2gl8","RETINOIC ACID RECEPTOR RXR-GAMMA","Homo sapiens",7,"TRP A  84;PHE A  92;ARG A  95;LEU A 105;ALA A 106;VAL A 121;CYH A 211","None","0.81A","1fm6A-2gl8A:26.8","1fm6A-2gl8A:85.60"],["1FM6_U_9CRU502_1","RETINOIC ACID RECEPTOR RXR-ALPHA","2gl8","RETINOIC ACID RECEPTOR RXR-GAMMA","Homo sapiens",7,"PHE A  92;ARG A  95;LEU A 105;ALA A 106;VAL A 121;ILE A 124;CYH A 211","None","0.75A","1fm6U-2gl8A:26.7","1fm6U-2gl8A:85.60"],["1FM9_A_9CRA201_1","RETINOIC ACID RECEPTOR RXR-ALPHA","2gl8","RETINOIC ACID RECEPTOR RXR-GAMMA","Homo sapiens",8,"TRP A  84;LEU A  88;PHE A  92;ARG A  95;LEU A 105;ALA A 106;VAL A 121;CYH A 211","None","0.74A","1fm9A-2gl8A:27.2","1fm9A-2gl8A:85.60"],["1G5Y_C_9CRC502_1","RETINOIC ACID RECEPTOR RXR-ALPHA","2gl8","RETINOIC ACID RECEPTOR RXR-GAMMA","Homo sapiens",6,"LEU A  88;SER A  91;PHE A  92;ARG A  95;LEU A 105;ALA A 106","None","0.88A","1g5yC-2gl8A:28.5","1g5yC-2gl8A:85.60"],["1K74_A_9CRA463_1","RETINOIC ACID RECEPTOR RXR-ALPHA","2gl8","RETINOIC ACID RECEPTOR RXR-GAMMA","Homo sapiens",8,"TRP A  84;LEU A  88;PHE A  92;ARG A  95;LEU A 105;ALA A 106;VAL A 121;CYH A 211","None","0.80A","1k74A-2gl8A:27.0","1k74A-2gl8A:85.60"],["1XDK_A_9CRA500_1","RETINOIC ACID RECEPTOR RXR-ALPHA","2gl8","RETINOIC ACID RECEPTOR RXR-GAMMA","Homo sapiens",7,"TRP A  84;PHE A  92;ARG A  95;LEU A 105;ALA A 106;VAL A 121;CYH A 211","None","0.78A","1xdkA-2gl8A:27.0","1xdkA-2gl8A:85.19"],["1XDK_E_9CRE1500_1","RETINOIC ACID RECEPTOR RXR-ALPHA","2gl8","RETINOIC ACID RECEPTOR RXR-GAMMA","Homo sapiens",7,"TRP A  84;PHE A  92;ARG A  95;LEU A 105;ALA A 106;VAL A 121;CYH A 211","None","0.78A","1xdkE-2gl8A:27.0","1xdkE-2gl8A:85.19"],["1XIU_A_9CRA201_1","RXR-LIKE PROTEIN","2gl8","RETINOIC ACID RECEPTOR RXR-GAMMA","Homo sapiens",6,"PHE A  92;ARG A  95;LEU A 105;ALA A 106;VAL A 121;CYH A 211","None","0.81A","1xiuA-2gl8A:28.0","1xiuA-2gl8A:78.01"],["1XIU_B_9CRB202_1","RXR-LIKE PROTEIN","2gl8","RETINOIC ACID RECEPTOR RXR-GAMMA","Homo sapiens",6,"LEU A  88;PHE A  92;ARG A  95;ALA A 106;VAL A 121;CYH A 211","None","0.57A","1xiuB-2gl8A:27.7","1xiuB-2gl8A:78.01"],["1XLS_A_9CRA801_1","RETINOIC ACID RECEPTOR RXR-ALPHA","2gl8","RETINOIC ACID RECEPTOR RXR-GAMMA","Homo sapiens",8,"TRP A  84;LEU A  88;PHE A  92;ARG A  95;LEU A 105;ALA A 106;VAL A 121;CYH A 211","None","0.79A","1xlsA-2gl8A:26.8","1xlsA-2gl8A:86.50"],["1XLS_B_9CRB802_1","RETINOIC ACID RECEPTOR RXR-ALPHA","2gl8","RETINOIC ACID RECEPTOR RXR-GAMMA","Homo sapiens",8,"TRP A  84;LEU A  88;PHE A  92;ARG A  95;LEU A 105;ALA A 106;VAL A 121;CYH A 211","None","0.78A","1xlsB-2gl8A:26.8","1xlsB-2gl8A:86.50"],["1XLS_C_9CRC803_1","RETINOIC ACID RECEPTOR RXR-ALPHA","2gl8","RETINOIC ACID RECEPTOR RXR-GAMMA","Homo sapiens",8,"TRP A  84;LEU A  88;PHE A  92;ARG A  95;LEU A 105;ALA A 106;VAL A 121;CYH A 211","None","0.78A","1xlsC-2gl8A:26.7","1xlsC-2gl8A:86.50"],["1XLS_D_9CRD804_1","RETINOIC ACID RECEPTOR RXR-ALPHA","2gl8","RETINOIC ACID RECEPTOR RXR-GAMMA","Homo sapiens",8,"TRP A  84;LEU A  88;PHE A  92;ARG A  95;LEU A 105;ALA A 106;VAL A 121;CYH A 211","None","0.79A","1xlsD-2gl8A:26.7","1xlsD-2gl8A:86.50"],["2ACL_A_REAA502_1","RETINOIC ACID RECEPTOR RXR-ALPHA;RETINOIC ACID RECEPTOR RXR-ALPHA","2gl8","RETINOIC ACID RECEPTOR RXR-GAMMA","Homo sapiens",6,"ASN A  85;LEU A  88;ARG A  95;ALA A 106;ILE A 124;CYH A 211","None","1.00A","2aclA-2gl8A:27.9;2aclE-2gl8A:27.7","2aclA-2gl8A:85.60;2aclE-2gl8A:85.60"],["2ACL_A_REAA502_1","RETINOIC ACID RECEPTOR RXR-ALPHA;RETINOIC ACID RECEPTOR RXR-ALPHA","2gl8","RETINOIC ACID RECEPTOR RXR-GAMMA","Homo sapiens",7,"LEU A  88;PHE A  92;ARG A  95;LEU A 105;ALA A 106;ILE A 124;CYH A 211","None","0.90A","2aclA-2gl8A:27.9;2aclE-2gl8A:27.7","2aclA-2gl8A:85.60;2aclE-2gl8A:85.60"],["2ACL_C_REAC503_1","RETINOIC ACID RECEPTOR RXR-ALPHA","2gl8","RETINOIC ACID RECEPTOR RXR-GAMMA","Homo sapiens",5,"PHE A  92;ARG A  95;ALA A 106;ILE A 124;CYH A 211","None","0.83A","2aclC-2gl8A:27.9","2aclC-2gl8A:85.60"],["2ACL_E_REAE504_1","RETINOIC ACID RECEPTOR RXR-ALPHA","2gl8","RETINOIC ACID RECEPTOR RXR-GAMMA","Homo sapiens",6,"LEU A  88;PHE A  92;ARG A  95;ALA A 106;ILE A 124;CYH A 211","None","0.94A","2aclE-2gl8A:27.7","2aclE-2gl8A:85.60"],["2ACL_G_REAG501_1","RETINOIC ACID RECEPTOR RXR-ALPHA","2gl8","RETINOIC ACID RECEPTOR RXR-GAMMA","Homo sapiens",6,"ASN A  85;ILE A  89;PHE A  92;ARG A  95;ALA A 106;CYH A 211","None","1.02A","2aclG-2gl8A:27.1","2aclG-2gl8A:85.60"],["2ACL_G_REAG501_1","RETINOIC ACID RECEPTOR RXR-ALPHA","2gl8","RETINOIC ACID RECEPTOR RXR-GAMMA","Homo sapiens",6,"ASN A  85;LEU A  88;ILE A  89;PHE A  92;ALA A 106;CYH A 211","None","0.71A","2aclG-2gl8A:27.1","2aclG-2gl8A:85.60"],["2ACL_G_REAG501_1","RETINOIC ACID RECEPTOR RXR-ALPHA","2gl8","RETINOIC ACID RECEPTOR RXR-GAMMA","Homo sapiens",6,"ILE A  89;PHE A  92;ARG A  95;LEU A 105;ALA A 106;CYH A 211","None","1.02A","2aclG-2gl8A:27.1","2aclG-2gl8A:85.60"],["2ACL_G_REAG501_1","RETINOIC ACID RECEPTOR RXR-ALPHA","2gl8","RETINOIC ACID RECEPTOR RXR-GAMMA","Homo sapiens",6,"LEU A  88;ILE A  89;PHE A  92;LEU A 105;ALA A 106;CYH A 211","None","0.86A","2aclG-2gl8A:27.1","2aclG-2gl8A:85.60"],["2AOF_C_FRDC305_2","POL POLYPROTEIN;PEPTIDE INHIBITOR","2gl8","RETINOIC ACID RECEPTOR RXR-GAMMA","Homo sapiens",4,"LEU A  79;ASP A  75;ALA A 159;ILE A  78","None","0.93A","2aofB-2gl8A:undetectable","2aofB-2gl8A:19.82"],["2CEO_B_T44B1395_1","THYROXINE-BINDING GLOBULIN","2gl8","RETINOIC ACID RECEPTOR RXR-GAMMA","Homo sapiens",5,"ALA A 159;LEU A 171;LEU A  71;LEU A 162;ASN A 164","None","1.36A","2ceoB-2gl8A:undetectable","2ceoB-2gl8A:20.82"],["2QQD_A_AG2A671_1","PYRUVOYL-DEPENDENT ARGININE DECARBOXYLASE (EC 4.1.1.19) (PVLARGDC);PYRUVOYL-DEPENDENT ARGININE DECARBOXYLASE (EC 4.1.1.19) (PVLARGDC)","2gl8","RETINOIC ACID RECEPTOR RXR-GAMMA","Homo sapiens",4,"LEU A 146;LEU A 204;ILE A 152;GLU A  21","None","1.06A","2qqdA-2gl8A:undetectable;2qqdE-2gl8A:undetectable","2qqdA-2gl8A:12.55;2qqdE-2gl8A:17.30"],["3DZU_A_9CRA7223_1","RETINOIC ACID RECEPTOR RXR-ALPHA","2gl8","RETINOIC ACID RECEPTOR RXR-GAMMA","Homo sapiens",6,"ASN A  85;ILE A  89;PHE A  92;ARG A  95;VAL A 121;CYH A 211","None","0.54A","3dzuA-2gl8A:26.7","3dzuA-2gl8A:48.28"],["3DZU_A_9CRA7223_1","RETINOIC ACID RECEPTOR RXR-ALPHA","2gl8","RETINOIC ACID RECEPTOR RXR-GAMMA","Homo sapiens",6,"ILE A  89;PHE A  92;ARG A  95;LEU A 105;VAL A 121;CYH A 211","None","0.60A","3dzuA-2gl8A:26.7","3dzuA-2gl8A:48.28"],["3DZY_A_9CRA463_1","RETINOIC ACID RECEPTOR RXR-ALPHA","2gl8","RETINOIC ACID RECEPTOR RXR-GAMMA","Homo sapiens",7,"ASN A  85;SER A  91;PHE A  92;ARG A  95;ALA A 106;VAL A 121;CYH A 211","None","0.95A","3dzyA-2gl8A:25.8","3dzyA-2gl8A:48.28"],["3DZY_A_9CRA463_1","RETINOIC ACID RECEPTOR RXR-ALPHA","2gl8","RETINOIC ACID RECEPTOR RXR-GAMMA","Homo sapiens",7,"SER A  91;PHE A  92;ARG A  95;LEU A 105;ALA A 106;VAL A 121;CYH A 211","None","0.93A","3dzyA-2gl8A:25.8","3dzyA-2gl8A:48.28"],["3E00_A_9CRA7223_1","RETINOIC ACID RECEPTOR RXR-ALPHA","2gl8","RETINOIC ACID RECEPTOR RXR-GAMMA","Homo sapiens",7,"TRP A  84;PHE A  92;ARG A  95;ALA A 106;VAL A 121;ILE A 124;CYH A 211","None","0.71A","3e00A-2gl8A:27.5","3e00A-2gl8A:48.28"],["3FAL_A_REAA501_1","RETINOIC ACID RECEPTOR RXR-ALPHA","2gl8","RETINOIC ACID RECEPTOR RXR-GAMMA","Homo sapiens",6,"PHE A  92;ARG A  95;ALA A 106;VAL A 121;ILE A 124;CYH A 211","None","0.76A","3falA-2gl8A:27.7","3falA-2gl8A:85.66"],["3FAL_C_REAC501_1","RETINOIC ACID RECEPTOR RXR-ALPHA","2gl8","RETINOIC ACID RECEPTOR RXR-GAMMA","Homo sapiens",6,"PHE A  92;ARG A  95;LEU A 105;ALA A 106;ILE A 124;CYH A 211","None","0.84A","3falC-2gl8A:28.1","3falC-2gl8A:85.66"],["3FC6_A_REAA501_1","RETINOIC ACID RECEPTOR RXR-ALPHA","2gl8","RETINOIC ACID RECEPTOR RXR-GAMMA","Homo sapiens",7,"TRP A  84;PHE A  92;ARG A  95;LEU A 105;ALA A 106;ILE A 124;CYH A 211","None","0.82A","3fc6A-2gl8A:28.1","3fc6A-2gl8A:85.66"],["3FC6_C_REAC501_1","RETINOIC ACID RECEPTOR RXR-ALPHA","2gl8","RETINOIC ACID RECEPTOR RXR-GAMMA","Homo sapiens",6,"LEU A  88;PHE A  92;ARG A  95;ALA A 106;VAL A 121;CYH A 211","None","0.73A","3fc6C-2gl8A:28.9","3fc6C-2gl8A:85.66"],["3FC6_C_REAC501_1","RETINOIC ACID RECEPTOR RXR-ALPHA","2gl8","RETINOIC ACID RECEPTOR RXR-GAMMA","Homo sapiens",6,"PHE A  92;ARG A  95;LEU A 105;ALA A 106;VAL A 121;CYH A 211","None","0.81A","3fc6C-2gl8A:28.9","3fc6C-2gl8A:85.66"],["3H0A_A_9RAA500_1","RETINOIC ACID RECEPTOR RXR-ALPHA","2gl8","RETINOIC ACID RECEPTOR RXR-GAMMA","Homo sapiens",6,"LEU A  88;ARG A  95;LEU A 105;VAL A 121;ILE A 124;CYH A 211","None","1.01A","3h0aA-2gl8A:25.7","3h0aA-2gl8A:88.60"],["3H0A_A_9RAA500_1","RETINOIC ACID RECEPTOR RXR-ALPHA","2gl8","RETINOIC ACID RECEPTOR RXR-GAMMA","Homo sapiens",6,"TRP A  84;LEU A  88;ARG A  95;LEU A 105;VAL A 121;ILE A 124","None","0.86A","3h0aA-2gl8A:25.7","3h0aA-2gl8A:88.60"],["3OAP_A_9CRA500_1","RETINOIC ACID RECEPTOR RXR-ALPHA","2gl8","RETINOIC ACID RECEPTOR RXR-GAMMA","Homo sapiens",7,"PHE A  92;ARG A  95;LEU A 105;ALA A 106;VAL A 121;ILE A 124;CYH A 211","None","0.71A","3oapA-2gl8A:28.5","3oapA-2gl8A:88.31"],["3UVV_B_9CRB501_1","RETINOIC ACID RECEPTOR RXR-ALPHA","2gl8","RETINOIC ACID RECEPTOR RXR-GAMMA","Homo sapiens",7,"LEU A  88;PHE A  92;ARG A  95;ALA A 106;VAL A 121;ILE A 124;CYH A 211","None","0.64A","3uvvB-2gl8A:28.0","3uvvB-2gl8A:85.66"],["4K6I_A_9RAA500_1","RETINOIC ACID RECEPTOR RXR-ALPHA","2gl8","RETINOIC ACID RECEPTOR RXR-GAMMA","Homo sapiens",6,"LEU A  88;ILE A  89;PHE A  92;ARG A  95;ALA A 106;VAL A 128","None","0.61A","4k6iA-2gl8A:28.1","4k6iA-2gl8A:88.31"],["4KLA_A_CHDA502_0","FERROCHELATASE, MITOCHONDRIAL","2gl8","RETINOIC ACID RECEPTOR RXR-GAMMA","Homo sapiens",5,"LEU A 154;LEU A  87;LEU A  88;ILE A  65;VAL A  24","None","1.37A","4klaA-2gl8A:undetectable","4klaA-2gl8A:22.69"],["4NQA_A_9CRA501_1","RETINOIC ACID RECEPTOR RXR-ALPHA","2gl8","RETINOIC ACID RECEPTOR RXR-GAMMA","Homo sapiens",5,"ILE A  89;ARG A 200;LEU A 204;ALA A 203;LEU A 215","None","1.05A","4nqaA-2gl8A:26.4","4nqaA-2gl8A:60.97"],["4NQA_A_9CRA501_1","RETINOIC ACID RECEPTOR RXR-ALPHA","2gl8","RETINOIC ACID RECEPTOR RXR-GAMMA","Homo sapiens",5,"PHE A  92;LEU A 105;ALA A 106;VAL A 121;CYH A 211","None","0.94A","4nqaA-2gl8A:26.4","4nqaA-2gl8A:60.97"],["5JI0_A_9CRA501_1","RETINOIC ACID RECEPTOR RXR-ALPHA","2gl8","RETINOIC ACID RECEPTOR RXR-GAMMA","Homo sapiens",8,"TRP A  84;LEU A  88;PHE A  92;ARG A  95;LEU A 105;ALA A 106;VAL A 121;CYH A 211","None","0.71A","5ji0A-2gl8A:27.6","5ji0A-2gl8A:84.84"],["5UAN_A_9CRA503_1","RETINOIC ACID RECEPTOR RXR-ALPHA","2gl8","RETINOIC ACID RECEPTOR RXR-GAMMA","Homo sapiens",6,"TRP A  84;PHE A  92;ARG A  95;ALA A 106;VAL A 121;CYH A 211","None","0.99A","5uanA-2gl8A:26.5","5uanA-2gl8A:60.97"],["5UAN_A_9CRA503_1","RETINOIC ACID RECEPTOR RXR-ALPHA","2gl8","RETINOIC ACID RECEPTOR RXR-GAMMA","Homo sapiens",6,"TRP A  84;PHE A  92;LEU A 105;ALA A 106;VAL A 121;CYH A 211","None","0.95A","5uanA-2gl8A:26.5","5uanA-2gl8A:60.97"],["5Z12_B_9CRB501_1","RETINOIC ACID RECEPTOR RXR-ALPHA","2gl8","RETINOIC ACID RECEPTOR RXR-GAMMA","Homo sapiens",8,"TRP A  84;LEU A  88;PHE A  92;ARG A  95;LEU A 105;ALA A 106;VAL A 121;CYH A 211","None","0.72A","5z12B-2gl8A:27.7","5z12B-2gl8A:83.75"],["5Z12_C_9CRC501_1","RETINOIC ACID RECEPTOR RXR-ALPHA","2gl8","RETINOIC ACID RECEPTOR RXR-GAMMA","Homo sapiens",7,"TRP A  84;PHE A  92;ARG A  95;LEU A 105;ALA A 106;VAL A 121;CYH A 211","None","0.70A","5z12C-2gl8A:26.9","5z12C-2gl8A:83.75"],["6A5Y_D_9CRD501_0","RETINOIC ACID RECEPTOR RXR-ALPHA","2gl8","RETINOIC ACID RECEPTOR RXR-GAMMA","Homo sapiens",7,"TRP A  84;PHE A  92;ARG A  95;LEU A 105;ALA A 106;ILE A 124;CYH A 211","None","0.77A","6a5yD-2gl8A:28.3","6a5yD-2gl8A:77.65"],["6A5Z_D_9CRD501_0","RETINOIC ACID RECEPTOR RXR-ALPHA","2gl8","RETINOIC ACID RECEPTOR RXR-GAMMA","Homo sapiens",7,"ILE A  89;PHE A  92;ARG A  95;LEU A 105;ALA A 106;ILE A 124;CYH A 211","None","0.69A","6a5zD-2gl8A:28.2","6a5zD-2gl8A:77.65"],["6A5Z_L_9CRL501_0","RETINOIC ACID RECEPTOR RXR-ALPHA","2gl8","RETINOIC ACID RECEPTOR RXR-GAMMA","Homo sapiens",6,"PHE A  92;ARG A  95;LEU A 105;ALA A 106;ILE A 124;CYH A 211","None","0.73A","6a5zL-2gl8A:28.2","6a5zL-2gl8A:77.65"],["6A60_D_9CRD501_0","RETINOIC ACID RECEPTOR RXR-ALPHA","2gl8","RETINOIC ACID RECEPTOR RXR-GAMMA","Homo sapiens",6,"LEU A  88;PHE A  92;ARG A  95;ALA A 106;ILE A 124;CYH A 211","None","0.67A","6a60D-2gl8A:28.0","6a60D-2gl8A:77.65"]]